A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment.

Clinical trial NCT01638000 · COMPLETED

Trial details

NCT number: NCT01638000
Sponsor: Astellas Pharma Europe Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Urologic Diseases Urinary Bladder, Overactive Urinary Bladder Diseases

Start date: 2012-06-12
Primary completion: 2013-04-24
Enrollment: 1887

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.